These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 8604747

  • 21. Relapse of CMV retinitis in an AIDS patient with high CD4 counts.
    Petit N, Zandotti C, Riss JM, Frippiat F, Moulin JF, Gastaut JA.
    J Antimicrob Chemother; 1998 Jun; 41(6):666-7. PubMed ID: 9687110
    [No Abstract] [Full Text] [Related]

  • 22. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Uthayakumar S, Birthistle K, Dalton R, Hay PE.
    Lancet; 1997 Aug 23; 350(9077):588-9; author reply 590. PubMed ID: 9284793
    [No Abstract] [Full Text] [Related]

  • 23. Anti-HIV drugs allow immune system to rebound, fight CMV.
    Optom Vis Sci; 2000 Jan 23; 77(1):3. PubMed ID: 10654853
    [No Abstract] [Full Text] [Related]

  • 24. Screening for cytomegalovirus retinitis at an AIDS clinic.
    Carmichael TR, Sher R.
    S Afr Med J; 2002 Jun 23; 92(6):445-7. PubMed ID: 12146128
    [No Abstract] [Full Text] [Related]

  • 25. Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS.
    Jabs DA.
    Br J Ophthalmol; 2001 Apr 23; 85(4):381-2. PubMed ID: 11264121
    [No Abstract] [Full Text] [Related]

  • 26. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.
    J Infect Dis; 1998 May 23; 177(5):1182-7. PubMed ID: 9593001
    [Abstract] [Full Text] [Related]

  • 27. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.
    Jacobson MA, Schrier R, McCune JM, Torriani FJ, Holland GN, O'Donnell JJ, Freeman WR, Bredt BM.
    J Infect Dis; 2001 May 01; 183(9):1399-404. PubMed ID: 11294673
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Margolis TP.
    Surv Ophthalmol; 2000 May 01; 44(5):455. PubMed ID: 10809654
    [No Abstract] [Full Text] [Related]

  • 32. Prevalence of cytomegalovirus retinitis in Tanzanians with low CD4 levels.
    Nirwoth JP, Hall AB, Lewallen S.
    Br J Ophthalmol; 2011 Apr 01; 95(4):460-2. PubMed ID: 21106992
    [Abstract] [Full Text] [Related]

  • 33. Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS.
    Jacobson MA, Tan QX, Girling V, Poon C, Van Natta M, Jabs DA, Inokuma M, Maecker HT, Bredt B, Sinclair E, Studies of Ocular Complications of AIDS Research Group.
    Clin Infect Dis; 2008 Feb 01; 46(3):458-66. PubMed ID: 18173357
    [Abstract] [Full Text] [Related]

  • 34. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.
    Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA.
    Am J Ophthalmol; 2000 May 01; 129(5):634-9. PubMed ID: 10844056
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Virus-specific antibody responses to human cytomegalovirus (HCMV) in human immunodeficiency virus type 1-infected persons with HCMV retinitis.
    Boppana SB, Polis MA, Kramer AA, Britt WJ, Koenig S.
    J Infect Dis; 1995 Jan 01; 171(1):182-5. PubMed ID: 7798660
    [Abstract] [Full Text] [Related]

  • 38. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R.
    Lancet; 1997 May 17; 349(9063):1443-5. PubMed ID: 9164318
    [Abstract] [Full Text] [Related]

  • 39. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Carr A, Cooper DA.
    Lancet; 1997 Aug 23; 350(9077):589; author reply 590. PubMed ID: 9284795
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.